Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kol A Zarember

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Circulation|September 21, 2014
Assessment of atherosclerosis in chronic granulomatous diseaseChristopher T Sibley, Tyra Estwick, Anna Zavodni, et al.
Emerging Infectious Diseases|August 26, 2010
Recurrent Granulibacter bethesdensis infections and chronic granulomatous diseaseDavid E Greenberg, Adam R Shoffner, Adrian M Zelazny, et al.
Infection and Immunity|December 21, 2011
Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogenKol A Zarember, Kimberly R Marshall-Batty, Anna R Cruz, et al.
Redox Biology|January 29, 2023
Development of an improved and specific inhibitor of NADPH oxidase 2 to treat traumatic brain injuryHannah Mason, Ganesha Rai, Arina Kozyr, et al.
Nature Biotechnology|March 8, 2016
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous diseaseSuk See De Ravin, Andreas Reik, Pei-Qi Liu, et al.
The Journal of Clinical Investigation|July 24, 2018
TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndromeIan A Myles, Erik D Anderson, Noah J Earland, et al.
Blood|May 22, 2010
Hypomorphic Rag mutations can cause destructive midline granulomatous diseaseSuk See De Ravin, Edward W Cowen, Kol A Zarember, et al.
Science Translational Medicine|April 22, 2016
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySuk See De Ravin, Xiaolin Wu, Susan Moir, et al.
Blood|August 26, 2016
Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyDouglas B Kuhns, Danielle L Fink, Uimook Choi, et al.
JCI Insight|November 24, 2020
An immune-based biomarker signature is associated with mortality in COVID-19 patientsMichael S Abers, Ottavia M Delmonte, Emily E Ricotta, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Circulation|September 21, 2014
Assessment of atherosclerosis in chronic granulomatous diseaseChristopher T Sibley, Tyra Estwick, Anna Zavodni, et al.
Emerging Infectious Diseases|August 26, 2010
Recurrent Granulibacter bethesdensis infections and chronic granulomatous diseaseDavid E Greenberg, Adam R Shoffner, Adrian M Zelazny, et al.
Infection and Immunity|December 21, 2011
Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogenKol A Zarember, Kimberly R Marshall-Batty, Anna R Cruz, et al.
Redox Biology|January 29, 2023
Development of an improved and specific inhibitor of NADPH oxidase 2 to treat traumatic brain injuryHannah Mason, Ganesha Rai, Arina Kozyr, et al.
Nature Biotechnology|March 8, 2016
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous diseaseSuk See De Ravin, Andreas Reik, Pei-Qi Liu, et al.
The Journal of Clinical Investigation|July 24, 2018
TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndromeIan A Myles, Erik D Anderson, Noah J Earland, et al.
Blood|May 22, 2010
Hypomorphic Rag mutations can cause destructive midline granulomatous diseaseSuk See De Ravin, Edward W Cowen, Kol A Zarember, et al.
Science Translational Medicine|April 22, 2016
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySuk See De Ravin, Xiaolin Wu, Susan Moir, et al.
Blood|August 26, 2016
Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyDouglas B Kuhns, Danielle L Fink, Uimook Choi, et al.
JCI Insight|November 24, 2020
An immune-based biomarker signature is associated with mortality in COVID-19 patientsMichael S Abers, Ottavia M Delmonte, Emily E Ricotta, et al.
Pageof 5